Environmental, Social And Governance (ESG) Report

Overview

The report presents KELUN PHARMA's 2023 group-wide ESG performance, including 19,798 employees worldwide and total Scope 1 and Scope 2 emissions of 2,659,459.92 tCO2e. It reports total energy consumption of 9,383,172.31 MWh and describes environmental management, resource conservation, and climate-risk responses. ESG oversight is led by the Board of Directors through an ESG Committee and ESG Working Group. The report also explains a materiality process that assessed 32 ESG topics using stakeholder and corporate-development dimensions.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 23 April 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services